细胞淋巴瘤-话题@MedSci

#细胞淋巴瘤#

385篇内容 | 5374人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1702368, encodeId=cc891e02368e8, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=CSMO 2014 ：弥漫大B细胞淋巴瘤预后分子标志物研究进展, objectType=article, longId=37556, objectId=87f43e55666, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87f43e55666, replyNumber=0, likeNumber=63, createdTime=2015-01-31, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87f43e55666, moduleTitle=CSMO 2014 ：弥漫大B细胞淋巴瘤预后分子标志物研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87f43e55666)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702374, encodeId=502b1e023746c, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=ASH 2014：Adcetris可改善复发性系统性间变性大细胞淋巴瘤患者生存, objectType=article, longId=44366, objectId=115544366e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=115544366e4, replyNumber=0, likeNumber=84, createdTime=2015-08-29, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=115544366e4, moduleTitle=ASH 2014：Adcetris可改善复发性系统性间变性大细胞淋巴瘤患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=115544366e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702367, encodeId=8aab1e023678c, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=CSMO 2014：朱军教授谈抗CD19 CART细胞在B细胞淋巴瘤中的临床应用, objectType=article, longId=37516, objectId=fc583e51605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc583e51605, replyNumber=0, likeNumber=72, createdTime=2014-10-13, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc583e51605, moduleTitle=CSMO 2014：朱军教授谈抗CD19 CART细胞在B细胞淋巴瘤中的临床应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc583e51605)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702363, encodeId=fc231e023630a, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=MYC基因异常的侵袭性B细胞淋巴瘤, objectType=article, longId=33867, objectId=96593386e81, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96593386e81, replyNumber=0, likeNumber=76, createdTime=2014-11-09, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96593386e81, moduleTitle=MYC基因异常的侵袭性B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96593386e81)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702362, encodeId=a4661e0236261, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NEJM：西妥昔单抗方案对纵隔B细胞淋巴瘤有较高治愈率, objectType=article, longId=32508, objectId=f0633250802, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0633250802, replyNumber=0, likeNumber=81, createdTime=2014-03-28, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0633250802, moduleTitle=NEJM：西妥昔单抗方案对纵隔B细胞淋巴瘤有较高治愈率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0633250802)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702370, encodeId=c9a11e0237065, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=CSMO 2014：王景文教授谈造血干细胞移植在治疗鼻型结外NK/T细胞淋巴瘤中的地位, objectType=article, longId=37659, objectId=09a53e6592b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09a53e6592b, replyNumber=0, likeNumber=54, createdTime=2014-08-09, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09a53e6592b, moduleTitle=CSMO 2014：王景文教授谈造血干细胞移植在治疗鼻型结外NK/T细胞淋巴瘤中的地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09a53e6592b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702366, encodeId=d6f11e02366e1, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=CSMO 2014：常乃柏教授谈浆母细胞淋巴瘤临床研究现状及治疗策略, objectType=article, longId=37515, objectId=f8cb3e515fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8cb3e515fb, replyNumber=0, likeNumber=53, createdTime=2014-08-04, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8cb3e515fb, moduleTitle=CSMO 2014：常乃柏教授谈浆母细胞淋巴瘤临床研究现状及治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8cb3e515fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702365, encodeId=a7951e02365aa, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=ASCO 2014：CSWOG鼻型结外NK/T细胞淋巴瘤的新分期系统, objectType=article, longId=35681, objectId=e1333568169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1333568169, replyNumber=0, likeNumber=67, createdTime=2014-12-22, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1333568169, moduleTitle=ASCO 2014：CSWOG鼻型结外NK/T细胞淋巴瘤的新分期系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1333568169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702369, encodeId=5b431e0236968, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=CSMO 2014 ：NK/T细胞淋巴瘤诊治新进展, objectType=article, longId=37606, objectId=e1023e60626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1023e60626, replyNumber=0, likeNumber=60, createdTime=2015-03-13, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1023e60626, moduleTitle=CSMO 2014 ：NK/T细胞淋巴瘤诊治新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1023e60626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702353, encodeId=fee61e02353c4, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NEJM：利妥昔单抗方案治疗纵隔B细胞淋巴瘤可避免放疗, objectType=article, longId=17564, objectId=f53c1e56400, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f53c1e56400, replyNumber=0, likeNumber=56, createdTime=2013-08-05, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f53c1e56400, moduleTitle=NEJM：利妥昔单抗方案治疗纵隔B细胞淋巴瘤可避免放疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f53c1e56400)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702361, encodeId=00681e02361f1, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=FDA批准Imbruvica(Ibrutinib)用于治疗套细胞淋巴瘤, objectType=article, longId=27987, objectId=44192e98757, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44192e98757, replyNumber=0, likeNumber=63, createdTime=2014-06-05, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44192e98757, moduleTitle=FDA批准Imbruvica(Ibrutinib)用于治疗套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44192e98757)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702354, encodeId=5ee51e0235445, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Lancet Oncol：Crizotinib可用于治疗炎性肌纤维母细胞瘤和间变性大细胞淋巴瘤儿童患者, objectType=article, longId=17725, objectId=1c411e72588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c411e72588, replyNumber=0, likeNumber=67, createdTime=2013-04-29, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c411e72588, moduleTitle=Lancet Oncol：Crizotinib可用于治疗炎性肌纤维母细胞瘤和间变性大细胞淋巴瘤儿童患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c411e72588)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702359, encodeId=e5bc1e02359b5, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=FDA：来那度胺获批用于套细胞淋巴瘤, objectType=article, longId=21326, objectId=39832132694, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39832132694, replyNumber=0, likeNumber=70, createdTime=2013-10-15, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39832132694, moduleTitle=FDA：来那度胺获批用于套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39832132694)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702356, encodeId=63ad1e023569d, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=ASCO 2013：中山大学林桐榆教授发现CHOP-B/IMVD/DHAP-三联循环方案治疗鼻型结外NK/T细胞淋巴瘤效果积极, objectType=article, longId=19008, objectId=c14c190080d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c14c190080d, replyNumber=0, likeNumber=80, createdTime=2014-03-16, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c14c190080d, moduleTitle=ASCO 2013：中山大学林桐榆教授发现CHOP-B/IMVD/DHAP-三联循环方案治疗鼻型结外NK/T细胞淋巴瘤效果积极, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c14c190080d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702357, encodeId=ac9e1e02357ff, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=ASCO 2013：新型生物标记物可用于弥漫大B细胞淋巴瘤分子分型及预后, objectType=article, longId=19867, objectId=f5a31986eb7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5a31986eb7, replyNumber=0, likeNumber=69, createdTime=2014-05-20, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5a31986eb7, moduleTitle=ASCO 2013：新型生物标记物可用于弥漫大B细胞淋巴瘤分子分型及预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5a31986eb7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702352, encodeId=03151e023529e, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Lancet Oncol：R-MegaCHOEP方案无益于年轻高危侵袭性B细胞淋巴瘤患者（(DSHNHL 2002-1研究）, objectType=article, longId=11320, objectId=310a11320c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=310a11320c6, replyNumber=0, likeNumber=65, createdTime=2013-04-26, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=310a11320c6, moduleTitle=Lancet Oncol：R-MegaCHOEP方案无益于年轻高危侵袭性B细胞淋巴瘤患者（(DSHNHL 2002-1研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=310a11320c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702358, encodeId=ac3c1e0235867, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Revlimid获准治疗特定套细胞淋巴瘤, objectType=article, longId=20175, objectId=dbe3201e596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbe3201e596, replyNumber=0, likeNumber=70, createdTime=2013-07-25, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbe3201e596, moduleTitle=Revlimid获准治疗特定套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbe3201e596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702360, encodeId=66a21e0236008, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=JCO：分子图谱有助于外周T细胞淋巴瘤分类, objectType=article, longId=22124, objectId=5f662212409, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f662212409, replyNumber=0, likeNumber=66, createdTime=2013-08-12, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f662212409, moduleTitle=JCO：分子图谱有助于外周T细胞淋巴瘤分类, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f662212409)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702355, encodeId=0b3b1e02355e6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=The Lancet：R-CHOP-21方案仍是新诊弥漫大B细胞淋巴瘤患者的标准一线方案, objectType=article, longId=18504, objectId=5cd51850457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cd51850457, replyNumber=0, likeNumber=67, createdTime=2013-10-22, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cd51850457, moduleTitle=The Lancet：R-CHOP-21方案仍是新诊弥漫大B细胞淋巴瘤患者的标准一线方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cd51850457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702351, encodeId=f3f41e02351c6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=EHA：套细胞淋巴瘤患者CNS事件不会立即致命, objectType=article, longId=7633, objectId=9ad2e63377, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ad2e63377, replyNumber=0, likeNumber=67, createdTime=2013-02-17, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ad2e63377, moduleTitle=EHA：套细胞淋巴瘤患者CNS事件不会立即致命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ad2e63377)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞淋巴瘤

2020-05-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

CSMO 2014 ：弥漫大B细胞淋巴瘤预后分子标志物研究进展

2015-01-31

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

ASH 2014：Adcetris可改善复发性系统性间变性大细胞淋巴瘤患者生存

2015-08-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

CSMO 2014：朱军教授谈抗CD19 CART细胞在B细胞淋巴瘤中的临床应用

2014-10-13

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

MYC基因异常的侵袭性B细胞淋巴瘤

2014-11-09

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NEJM：西妥昔单抗方案对纵隔B细胞淋巴瘤有较高治愈率

2014-03-28

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

CSMO 2014：王景文教授谈造血干细胞移植在治疗鼻型结外NK/T细胞淋巴瘤中的地位

2014-08-09

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

CSMO 2014：常乃柏教授谈浆母细胞淋巴瘤临床研究现状及治疗策略

2014-08-04

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

ASCO 2014：CSWOG鼻型结外NK/T细胞淋巴瘤的新分期系统

2014-12-22

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

CSMO 2014 ：NK/T细胞淋巴瘤诊治新进展

2015-03-13

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NEJM：利妥昔单抗方案治疗纵隔B细胞淋巴瘤可避免放疗

2013-08-05

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

FDA批准Imbruvica(Ibrutinib)用于治疗套细胞淋巴瘤

2014-06-05

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Lancet Oncol：Crizotinib可用于治疗炎性肌纤维母细胞瘤和间变性大细胞淋巴瘤儿童患者

2013-04-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

FDA：来那度胺获批用于套细胞淋巴瘤

2013-10-15

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

ASCO 2013：中山大学林桐榆教授发现CHOP-B/IMVD/DHAP-三联循环方案治疗鼻型结外NK/T细胞淋巴瘤效果积极

2014-03-16

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

ASCO 2013：新型生物标记物可用于弥漫大B细胞淋巴瘤分子分型及预后

2014-05-20

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Lancet Oncol：R-MegaCHOEP方案无益于年轻高危侵袭性B细胞淋巴瘤患者（(DSHNHL 2002-1研究）

2013-04-26

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Revlimid获准治疗特定套细胞淋巴瘤

2013-07-25

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

JCO：分子图谱有助于外周T细胞淋巴瘤分类

2013-08-12

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

The Lancet：R-CHOP-21方案仍是新诊弥漫大B细胞淋巴瘤患者的标准一线方案

2013-10-22

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

EHA：套细胞淋巴瘤患者CNS事件不会立即致命

2013-02-17

科室
- - 订阅+
  - 更多科室
工具
服务